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Abstract
Background: In England, NHS Blood and Transplant conducts national audits of transfusion and provides feedback
to hospitals to promote evidence-based practice. Audits demonstrate 20% of transfusions fall outside guidelines.
The AFFINITIE programme (Development & Evaluation of Audit and Feedback INterventions to Increase evidence-
based Transfusion practIcE) involves two linked, 2×2 factorial, cluster-randomised trials, each evaluating two
theoretically-enhanced audit and feedback interventions to reduce unnecessary blood transfusions in UK hospitals.
The first intervention concerns the content/format of feedback reports. The second aims to support hospital
transfusion staff to plan their response to feedback and includes a web-based toolkit and telephone support.
Interpretation of trials is enhanced by comprehensively assessing intervention fidelity. However, reviews
demonstrate fidelity evaluations are often limited, typically only assessing whether interventions were delivered as
intended. This protocol presents methods for assessing fidelity across five dimensions proposed by the Behaviour
Change Consortium fidelity framework, including intervention designer-, provider- and recipient-levels.
Methods: (1) Design: Intervention content will be specified in intervention manuals in terms of component behaviour
change techniques (BCTs). Treatment differentiation will be examined by comparing BCTs across intervention/standard
practice, noting the proportion of unique/convergent BCTs. (2) Training: draft feedback reports and audio-recorded
role-play telephone support scenarios will be content analysed to assess intervention providers’ competence to deliver
manual-specified BCTs. (3) Delivery: intervention materials (feedback reports, toolkit) and audio-recorded telephone
support session transcripts will be content analysed to assess actual delivery of manual-specified BCTs during the
intervention period. (4) Receipt and (5) enactment: questionnaires, semi-structured interviews based on the Theoretical
Domains Framework, and objective web-analytics data (report downloads, toolkit usage patterns) will be analysed to
assess hospital transfusion staff exposure to, understanding and enactment of the interventions, and to identify
contextual barriers/enablers to implementation. Associations between observed fidelity and trial outcomes (%
unnecessary transfusions) will be examined using mediation analyses.
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Discussion: If the interventions have acceptable fidelity, then results of the AFFINITIE trials can be attributed to
effectiveness, or lack of effectiveness, of the interventions. Hence, this comprehensive assessment of fidelity will be
used to interpret trial findings. These methods may inform fidelity assessments in future trials.
Trial registration: ISRCTN 15490813. Registered 11/03/2015
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Background
Blood transfusion is one of the most widely and
frequently used clinical interventions. However, a
substantial proportion of transfusions is considered un-
necessary, in that they are administered to patients
where clinical studies suggest no clear benefit [1]. Not
only are blood components (i.e. red cells, platelets,
plasma) scarce and costly resources, but unnecessary
transfusions place patients at risk of harm (e.g. of med-
ical adverse events, such as transfusion reactions, or
errors in patient identification) [2]. Hence, strategies are
needed to reduce unnecessary use of blood components
by changing current transfusion practice.
One strategy with the potential to achieve such change
is audit and feedback (A&F). A&F is defined as a ‘sum-
mary of clinical performance of healthcare over a specified
time period, to provide healthcare professionals with data
on performance’ [3]. In England, the National Health Ser-
vice Blood and Transplant (NHSBT) National Compara-
tive Audit (NCA) programme runs national audits
designed to assess whether blood components are being
used appropriately and safely across clinical specialties [4].
The NCA’s approach to A&F has remained largely un-
changed since its establishment in 2003. In brief, an audit-
writing group is convened, usually consisting of an audit
lead (typically a consultant haematologist with an interest
in transfusion), statistician and clinical staff representa-
tives from the clinical specialty being audited (e.g. ortho-
paedics). This group is responsible for agreeing the audit
standards against which clinical practice will be compared,
data to be collected, and the findings and recommenda-
tions to be included in feedback reports. Resulting feed-
back reports are subsequently uploaded and delivered to
the hospital transfusion team (i.e. transfusion practitioner,
consultant haematologist, transfusion laboratory manager)
via a hospital-specific NCA audit webpage. It is intended
or assumed that this team will subsequently disseminate
these reports within their hospitals, and, where feedback
indicates discrepancies between current practice and audit
standards, lead on a planning process to encourage prac-
tice change. However, the NCA currently provides no
formal support to facilitate such planning.
Although there have been some incremental improve-
ments (i.e. reductions) in use of blood products over
recent years, a consistent finding from these audits is
that usage of blood components by different clinical spe-
cialities remains higher than indicated by evidence-based
guidelines; with approximately 1 in 5 transfusions falling
outside national recommendations [5]. This raises ques-
tions regarding the effectiveness of current A&F strat-
egies in this context—a concern mirrored in the wider
A&F literature [3, 6]. A Cochrane review demonstrated
that although A&F interventions have modest, albeit
worthwhile, effects on clinical practice (median +4%),
outcomes across A&F interventions are highly variable
(IQR 0.5 to 16%) [3]. Reasons underpinning this hetero-
geneity are unclear [3, 7]. It has been argued that the
systematic application of evidence and behaviour change
theory has the potential to enhance the effectiveness of
A&F interventions [6].
Development & Evaluation of enhanced Audit & Feedback
Interventions to Increase uptake of evidence-based trans-
fusion practice: the AFFINITIE programme
The AFFINITIE research programme is funded by the
UK’s National Institute of Health Research and is con-
ducted in collaboration with NHSBT. AFFINITIE uses
the NCA as a platform for applying existing evidence as
to what makes feedback more effective (i.e. A&F
Cochrane review [3]), and behavioural theory (i.e. con-
trol theory [8]) to develop and evaluate two enhanced
feedback interventions. AFFINITIE consists of four
workstreams (Fig. 1). The protocol for intervention de-
velopment (Workstream 1; Fig. 1) has been published
elsewhere [9].
Briefly, Intervention 1 (‘enhanced content’) concerns
the content and format of feedback reports delivered to
hospitals. It is a cascade intervention consisting of two
components. First, an enhancement guidance manual
targeted at the NCA audit-writing group, which includes
guidance on how to apply five proposed enhancements
for writing feedback reports with evidence- and theory-
based content. The proposed enhancements were identi-
fied following a content analysis of previous NCA
feedback reports. This examined whether effective com-
ponents of A&F identified in the A&F Cochrane Review,
and behaviour change techniques (BCTs) [10] consistent
with control theory (e.g. goal setting, feedback, action
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planning) [7] featured in existing reports. It is intended
that the audit-writing group will apply this guidance to
produce a template feedback report with enhanced con-
tent, which will subsequently be populated with
hospital-specific audited data. The second component in
the cascade is the resulting feedback report, which will
be uploaded to each hospital’s individual NCA webpage,
where intervention recipients (i.e. hospital transfusion
team) can access and download their reports.
Intervention 2 (‘enhanced follow-on’) concerns the
actions taken in hospitals in response to feedback re-
ports and aims to support relevant hospital transfu-
sion staff to plan their response to the feedback. It
consists of a web-based toolkit for use by the hospital
transfusion team. The toolkit aims to facilitate three
behaviours in response to feedback: (i) dissemination
of findings to all relevant clinical staff involved in
transfusion decision making; (ii) goal setting, problem
solving and action planning to facilitate practice
changes in response to feedback; and (iii) continued
re-monitoring of the clinical practices that were
audited. The toolkit will be accessible to hospital staff
via a web-link uploaded to the hospital-specific NCA
webpage. As a co-intervention to prompt engagement
with the toolkit, hospital transfusion teams will re-
ceive an initial telephone support call from an inter-
vention provider, offering support and advice on how
to use the toolkit. A telephone line will subsequently
be available for hospitals to contact intervention pro-
viders for further support as needed.
The effectiveness and cost-effectiveness of both inter-
ventions will be evaluated in two sequential, linked, 2×2
factorial, pragmatic cluster-randomised controlled trials
(RCTs) (Workstream 2; Figs. 1 and 2). Trial 1 audits
clinical management and transfusion decision-making
for elective surgical patients. Trial 2 audits appropriate-
ness of red cell and platelet transfusions in haematology
patients. The comparator for both interventions is
NCA’s existing, standard A&F practice (i.e. clinically led
feedback report; no formalised follow-on support). The
primary outcome is the proportion of unnecessary trans-
fusions administered, to be evaluated through a re-audit
of key clinical behaviours approximately 9 months fol-
lowing intervention delivery.
However, A&F is a complex, multilevel, multicompo-
nent intervention and is therefore susceptible to vari-
ation in implementation. Intervention fidelity refers to
ongoing assessment, monitoring and enhancement of
the reliability and internal validity of an intervention
study [11]. It broadly involves investigating the extent to
which interventions are implemented as originally
intended [12]. Therefore, the AFFINITIE programme
also includes a parallel process evaluation (Workstream
3; Fig. 1) focused on assessing fidelity in each cluster-
RCT to explore how the interventions succeed or fail in
reducing unnecessary transfusions.
Fig. 1 AFFINITIE programme workstreams overview
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The AFFINITIE process evaluation
Theoretical models and frameworks of fidelity argue that
fidelity is a multidimensional concept, relevant at inter-
vention designer-, provider- and recipient-levels [11].
However, fidelity assessments of complex interventions
rarely look at the ‘whole picture,’ and often focus on
investigating a single dimension of fidelity; typically
whether or not intervention providers delivered inter-
ventions as specified, and less so whether intervention
recipients comprehend, engage with or enact interven-
tions as intended [13–15]. Assessing recipient-level fidel-
ity is particularly important for interventions such as the
AFFINITIE feedback interventions. Both interventions’
components are standardised across recipients and are
delivered only once (i.e. both the feedback report link
and web link to the toolkit are delivered once, digitally,
although both resources are available to recipients
throughout the 9-month intervention period). The inter-
ventions are thus likely to display limited variability in
designer/provider-level fidelity. Rather, it is likely that
any variability in observed outcomes may in part be
attributable to variation in whether and how transfusion
clinical staff receiving the feedback interventions initially
understand, engage with and subsequently enact the
interventions in day-to-day clinical practice [16].
Therefore, we aim to adopt a multidimensional frame-
work to assess fidelity, by applying the US National
Institute of Health Behaviour Change Consortium’s
(BCC) fidelity framework and guidance [11]. This frame-
work proposes five fidelity dimensions: (1) Design:
treatment differentiation, acceptability, comprehensive
specification of intervention components, theoretical
underpinning and causal assumptions; (2) Training:
extent to which intervention providers are competent
and adequately trained to deliver interventions; (3) De-
livery: extent to which intervention content is delivered
as intended during the intervention period; (4) Receipt:
whether intervention recipients initially understand/
engage with the intervention; and (5) Enactment: extent
to which recipients apply the intervention as intended in
‘real life’ or target settings (e.g. clinical practice). It is
important to assess fidelity across all five dimensions, as
lack of fidelity to just one could affect study outcomes
and thus the internal validity of the trial [12].
Moreover, outcomes and enactment across partici-
pants may be facilitated or hindered by contextual fac-
tors external to the intervention (e.g. organisational
norms, policy, available resources) [17]. In AFFINITIE,
external factors, such as the publication of new transfu-
sion clinical guidelines [18], may impact on responses to
the interventions and observed outcomes. Some factors
may influence intervention and control arms equally,
while others may interact with or duplicate active com-
ponents in the interventions. Therefore, to facilitate
interpretation of fidelity and outcome data, a secondary
objective of the AFFINITIE process evaluation is to
explore potential contextual factors influencing fidelity
of receipt and enactment.
Aims
The aims of the study are to conduct a multidimensional
assessment of fidelity for two enhanced feedback
Fig. 2 AFFINITIE sequential, replicate 2×2 pragmatic cluster-randomised controlled trial design
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interventions and assess the extent to which fidelity
contributes to observed outcomes (i.e. proportion of
unnecessary transfusions). The specific research ques-
tions map onto the BCC fidelity dimensions:
1. To what extent: (i) are the two enhanced feedback
interventions clearly specified a priori, and (ii) is it
possible to differentiate between the components of
the two enhanced interventions and standard
practice comparators (design)?
2. To what extent have the feedback interventions been
delivered as intended by intervention providers
(training/delivery)?
3. To what extent were the feedback interventions
received and enacted as intended by transfusion
clinical staff in UK hospitals (receipt/enactment)?
4. What are the contextual influences that might have
influenced clinical staffs’ responses to the feedback
interventions?
5. To what extent do measures of fidelity mediate
observed outcomes?
Methods
Overall process evaluation design
Two linked, mixed-method fidelity assessments will be
conducted in parallel to the two linked cluster-RCTs.
Table 1 outlines how each sub-dimension of the five
BCC fidelity dimensions [11] will be addressed in AFFI-
NITIE. A summary of how each fidelity dimension will
be investigated will be presented in turn.
Fidelity of design
Considerations regarding fidelity of design fall broadly
into two categories: (1) trial design and (2) intervention
design [11]. The internal validity of any study will be
impacted by whether the selected trial design can
adequately test proposed hypotheses. In AFFINITIE, this
has been considered as part of Workstream 2 (Fig. 1),
via the selection of a 2×2, factorial, cluster-RCT design,
and will be discussed in a separate trial protocol.
Fidelity of intervention design concerns how compre-
hensively interventions are specified a priori, whether
intervention components adequately reflect underlying
theory, and intervention acceptability [13]. Such consid-
erations have been addressed as part of intervention
development in Workstream 1 (Fig. 1). Intervention
delivery parameters (i.e. dose/ duration/ number of con-
tacts) and content (i.e. component BCTs) have been spe-
cified a priori using BCT labels and definitions from an
established BCT taxonomy [10]. The BCTs in each inter-
vention were then mapped onto control theory [8].
Throughout the intervention development process,
multidisciplinary experts (behaviour change scientists,
transfusion clinical staff, patient representatives) have
iteratively reviewed the interventions to consider
whether the interventions have clinical face validity and
reflect their proposed theory- and evidence-base [3, 8].
Pilot work has been conducted to assess the feasibility
and acceptability of the interventions using think-aloud
protocols [19] and semi-structured interviews [9].
An additional fidelity of design consideration is treat-
ment differentiation, defined as the degree to which
treatments (i.e. interventions), or two or more trial arms
differ as intended along critical dimensions (e.g. content)
[12]. Treatment differentiation is of particular import-
ance to the AFFINITIE pragmatic cluster-RCTs, which
aim to evaluate the effectiveness of two feedback inter-
ventions (individually and combined), against current
standard NCA feedback practice (Fig. 2). The ability to
meaningfully conduct such evaluations depends on a
minimum degree of differentiation between the inter-
ventions and standard practice comparators.
Treatment differentiation of the interventions as
designed will be assessed by conducting comparisons
between the content of (1) intervention 1 ‘enhanced
content’ vs current standard practice (i.e. clinically led
feedback reports); (2) intervention 2 ‘enhanced follow-
on support’ vs current standard practice (i.e. no forma-
lised follow-on support); and (3) intervention 1 ‘en-
hanced content’ vs intervention 2 ‘enhanced follow-on
support.’ The intended content of each intervention and
comparator will be coded by two independent coders
into component BCTs using a BCT taxonomy [10].
BCTs will be compared across both interventions and
standard practice comparators in terms of BCT fre-
quency, mode of delivery, behavioural specificity—in-
cluding relation to target behaviours and enactment
instructions. BCTs that are identified at least once in
either intervention or comparator will be categorised as
‘fully convergent’ (i.e. present in both the intervention
and comparator with similar frequency, mode of deliv-
ery, extent of behavioural specificity and enactment
instructions); ‘partially convergent’ (i.e. present in both
the intervention and comparator, but with differing
frequencies, modes of delivery, extent of behavioural
specificity and enactment instructions), or ‘unique’ (i.e.
present only in the intervention or comparator). For
each of the three comparisons, the percentage of BCTs
in each of these categories will be noted. A higher pro-
portion of ‘fully’ or ‘partially convergent’ BCTs indicates
lower treatment differentiation. Inter-rater coding reli-
ability will be assessed using Cohen’s kappa, with a value
of k = 0.75 taken to represent high agreement [20].
Fidelity of training
The BCC guidance advocates standardisation of training
between intervention providers and checking providers
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Table 1 BCC fidelity dimensions (Bellg et al. [11]) and their application in the AFFINITIE trial
Fidelity dimensions Application intervention 1 (enhanced
content—feedback reports)
Application intervention 2 (enhanced follow-on
support—web-based toolkit + telephone support)
Design
Provide information about treatment dose in
intervention and control/comparison condition:
length of contacts (min), number of contacts,
content of treatment, duration of contact over
time
• Intervention content and delivery parameters described in separate intervention development
papers for each intervention
• Description of intervention content in terms of component behaviour change techniques (BCTs)
using established BCT taxonomy
• Treatment differentiation: comparison of BCTs between both interventions and between each
intervention and corresponding current standard practice comparator. BCTs will be compared in
terms of frequency, mode of delivery, behavioural specificity and enactment instruction. BCTs that
are identified at least once in either intervention and/or comparator will be classified as either fully
convergent (present in similar frequency/mode of delivery/behavioural specificity/enactment
instruction in both intervention/comparator), partially convergent (present in both, but at different
frequencies/ modes of delivery/ behavioural specificity/ enactment instruction) or unique (present
in only intervention or comparator). The percentage of BCTs in each category will be assessed,
with a higher proportion of fully/partially convergent BCTs indicating lower treatment differentiation.
Method to ensure dose is equivalent between
conditions.
• Hospitals in the intervention and control trial
arms for intervention 1 will both receive at
least one feedback report and feedback
PowerPoint presentations as per standard
practice.
• However, dose may differ in terms of the
number of feedback reports received per
condition, as the enhanced feedback report
condition includes multiple feedback reports
following a graded entry approach (i.e. level
1—key findings→ level 3—detailed
supplementary findings report).
• N/A; All hospitals randomised to the enhanced
condition for intervention 2 will receive the
toolkit and initial telephone support at
equivalent doses. However, hospitals in the
control condition for intervention 2 will not
receive an equivalent dose of intervention 2 as
the comparator is a standard practice/no
intervention condition.
Method to ensure dose is equivalent for
participants within conditions.
• The enhancement guidance manual will be
used to produce a report template containing
the proposed enhancements, which will be
populated with hospital specific data for each
hospital. Using a template report will help
ensure the format and content of reports is
consistent across hospital specific reports.
• The same web-based toolkit will be delivered
to all intervention 2 hospitals. Dose is standard
within condition.
• All hospitals will receive one initial facilitator-
initiated telephone support call.
Specification of intervention provider
credentials that are needed
• Described under training dimension
Theoretical model upon which the intervention
is based is clearly articulated: - The active
ingredients are specified and incorporated into
the intervention. - Use of experts or protocol
review group to determine whether the
intervention protocol reflects the underlying
theoretical model or clinical guidelines.
• Intervention causal assumptions, theory (control theory) and evidence base (Cochrane audit and
feedback review) summarised in logic models reported in intervention development papers.
• Component BCTs in each intervention mapped onto control theory
• Interventions developed in collaboration with multidisciplinary consensus panel (transfusion
clinical staff, behavioural scientists, patient representatives) to ensure the interventions reflect the
underlying theoretical models and hold clinical face validity
Potential confounders that limit the ability to
make conclusions at the end of the trial are
identified.
• Possible contamination threats (e.g. regional transfusion committee meetings) will be
continuously monitored and documented throughout the AFFINITIE trials.
• Wider contextual factors external to the AFFINITIE trials that may influence intervention outcomes
will be examined via the process evaluation (e.g. publication of new NICE transfusion clinical
guidelines).
Plan to address possible setbacks in
implementation (i.e. back-up systems or
providers)
• NHS Blood and Transplant and the National
Comparative Audit have employed extra staff
to support the conduct of the audits and trial
data collection. IT staff are available to support
systems issues for report upload. These
measures will help ensure the audits keep to
timeline.
• NHS Blood and Transplant and the National
Comparative Audit have employed extra staff to
support the conduct of the audits and trial data
collection. These measures will help ensure the
audits keep to timeline. IT staff have also been
appointed to support the maintenance of the
web-based toolkit.
• Further telephone support will be available,
whereby hospitals may speak to an intervention
provider to discuss any issues encountered with
using the web-based toolkit.
If more than one intervention is described, all
interventions are described equally well
• Intervention will be described in intervention
development paper using relevant reporting
checklist (identified via the Enhancing the
• Intervention will be described in intervention
development paper using relevant reporting
checklist (identified via the Enhancing the
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Table 1 BCC fidelity dimensions (Bellg et al. [11]) and their application in the AFFINITIE trial (Continued)
Quality and Transparency Of Health Research
network http://www.equator-network.org/home/)
Quality and Transparency Of Health Research
network http://www.equator-network.org/home/)
Training
Description of how providers will be trained
(manual of training procedures)
• Training procedures outlined in intervention development papers
• Training log to document training delivered for each intervention
Standardisation of provider training (especially if
multiple waves of training are needed for
multiple groups of providers)
• Standardised training materials, including an
enhancement guidance manual and
prototype training reports
• One full-day training workshop delivered by
intervention developers for enhanced audit
writing group intervention developers
• Standardised training materials, including a
telephone support manual and flow chart
• Three training sessions delivered by intervention
developers to intervention facilitators
Assessment of provider skill acquisition • Preliminary draft enhanced reports will be
content analysed to assess the extent to which
proposed enhancements and theoretically
consistent BCTs have been applied as intended
• Documented in a skill acquisition record form
• Intervention facilitators role-play delivery of
telephone support sessions to a range of pos
sible scenarios
• Assess extent to which intended BCTs are
delivered according to the telephone support
manual
• Documented in skill acquisition record form
Characteristics being sought and/or avoided in
a treatment provider are articulated a priori.
• Not met: audit lead and report writing group
recruited by the National Comparative Audit
of blood transfusion as per standard audit
practice
• Requisite knowledge and skills for intervention
providers outlined in job description
At the hiring stage, assessment of whether or
not there is a good fit between the provider
and the intervention (e.g. ensure that providers
find the intervention acceptable, credible and
potentially efficacious).
• Not met: audit lead and report writing group
recruited by the National Comparative Audit
of blood transfusion as per standard audit
practice
• Interview questions and tasks (e.g. BCT coding
exercise) were chosen to assess whether
applicants for the intervention facilitator roles
possessed requisite knowledge and skills in
behaviour change.
Delivery
Method to ensure that content and dose of
intervention is delivered as specified.
• Provision of an enhancement guidance
manual and enhancement application ‘checklist’
• Telephone support manual, telephone support
flow chart and BCT checklist
• Telephone support delivery log
Assessment and monitoring of provider skill
maintenance over time
• Promoted by intervention developers
providing ongoing support to audit writing
group during preparation of the reports (i.e.
iterative review of draft reports and feedback
on how to increase delivery of proposed
enhancements and theoretically consistent
BCTs)
• Analysis of sub-sample of audio-recorded tele
phone support sessions
• Assess the extent to which BCTs according to
the telephone support manual and flowchart
are delivered across intervention delivery period
Mechanism to assess if the provider actually
adhered to the intervention plan/use of
treatment manual/whether active ingredients
delivered
• Content analysis of template for enhanced
reports to check for application of intended
enhancements
• Content analysis of toolkit + sub-sample of
audio-recorded telephone support sessions to
check that intended BCTs delivered
In the case of computer delivered interventions,
method to assess participants’ contact with the
information
• See receipt component; web-analytics data
will be collected on participant engagement
with interventions in terms of number of down
loads of each feedback report from the hospital
web-page
• See receipt component; web-analytics data
will be collected on participant engagement
with interventions in terms of number of log
ins into the toolkit
There is a plan for the assessment of whether
or not proscribed components were delivered
(e.g. components that are unnecessary or
unhelpful)
• The enhancement guidance specifies three
different graded entry levels of feedback reports
and outlines the format and BCTs that are to be
delivered in each report. A content analysis will
be conducted of the template for the different
levels of the feedback reports to verify whether
any proscribed components were included in
each report
• Content analysis of feedback reports delivered
to standard/comparator arm to monitor for
possible contamination/loss of treatment
differentiation in terms of BCTs delivered
• Telephone support providers have been
instructed to maintain treatment discrimination
between the trial arms by not discussing what
is being delivered in other trial arms when
providing telephone support. A sub-sample of
telephone support sessions will be audio-
recorded and examined for disclosure of con
tent delivered across trial arms
There is a plan for how contamination between
conditions will be prevented
• Two separate but equivalent feedback report
writing groups have been established to write
the enhanced and standard feedback reports
• Intervention facilitators will deliver telephone
support on two separate proactive and reactive
telephone support lines (one for hospitals
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Table 1 BCC fidelity dimensions (Bellg et al. [11]) and their application in the AFFINITIE trial (Continued)
• A protocol for documenting and monitoring
possible sources of contamination has been
developed and will be implemented
throughout the trial. AFFINITIE does not aim to
prevent contamination, but rather document it
receiving enhanced reports, and one for
hospitals receiving standard reports)
• A protocol for documenting and monitoring
possible sources of contamination has been
developed and will be implemented
throughout the trial
There is an a priori specification of treatment
fidelity (e.g. providers adhere to delivering
>80% components)
• Using general consensus criteria, 80–100%
adherence to intervention components will
be classed as high fidelity; 51–79% moderate;
and <50% low fidelity
Method to ensure that content and dose of
intervention is delivered as specified
• Content analysis of template for enhanced
reports to check for application of intended
enhancements
• Examination of each NCA hospital web-page
to check whether the intended feedback re
port(s) were uploaded according to trial arm
allocation
• Content analysis of toolkit + sub-sample of
audio-recorded telephone support sessions to
check that intended BCTs delivered
• Examination of each NCA hospital web-page
to check that a link to the web-based toolkit
was delivered to the intended hospitals
according to trial arm allocation
•Telephone support delivery log
Receipt
There is an assessment of the degree to which
participants understood the intervention
• Questionnaires sent to clinical staff in all
participating hospitals three months post
intervention delivery to assess the extent to
which they understood the key findings and
recommendations in the feedback reports
• Semi-structured interviews with clinical staff in
a sub-sample of hospitals to examine in greater
depth the extent to which clinical staff under
stood the content of the feedback reports
• Questionnaires sent to clinical staff in all
participating hospitals allocated to receive
intervention 2 3 months post intervention
delivery to assess the extent to which they
understood how to use the toolkit
• Semi-structured interviews with clinical staff in
a sub-sample of hospitals to examine in
greater depth the extent to which the clinical
staff understood how to use the toolkit
There is specification of strategies that will be
used to improve participant comprehension of
the intervention
• The enhanced feedback reports were piloted
in four hospitals to assess feasibility and
acceptability. The reports and enhancement
guidance were revised post piloting
accordingly, to maximise comprehension and
acceptability
• The toolkit was piloted in four hospitals to
assess feasibility and acceptability. The toolkit
was revised post piloting accordingly, to
maximise comprehension and acceptability
• Subsequent versions of the toolkit were subject
to additional usability testing in hospitals and
refined as necessary prior to trial
The participants’ ability to perform the
intervention skills will be assessed during the
intervention period
• Intervention 1 is delivered only once, and
there are no pre-specified skills hospitals are
expected to perform for Intervention 1 during
intervention delivery.
• Web analytics of toolkit data (e.g. extent of
completion of the dissemination, goal setting,
problem solving and action planning tasks)
A strategy will be used to improve subject
performance of intervention skills during the
intervention period.
• Not met: intervention 1 is only delivered once;
no additional contacts will be made with
hospitals by the audit writing group following
delivery of the feedback reports
• Intervention 2 as a whole aims to improve
transfusion clinical staffs’ response to feedback
by supporting clinical staff to plan their
dissemination and response to feedback.
• Provision of an initial facilitator-initated
telephone support session to all hospitals
allocated to receive intervention 2, to encourage
engagement with the toolkit and discuss any
initial issues or questions
• Additional telephone support will be available
on an as needed basis to all hospitals
receiving intervention 2 for 3 months
following intervention delivery
Multicultural factors considered in the
development of and delivery of the
intervention (e.g. provide in native language;
protocol is consistent with the values of the
target group)
• The enhanced A&F interventions were developed
in continuous consultation and discussion with
the range of clinical staff involved in transfusion
(i.e. consultant haematologists, lab managers,
transfusion practitioners, nurses, etc.).
• Interventions were piloted to assess feasibility
and acceptability in this clinical context and
refined as necessary to address any
emerging issues.
Enactment
Strategy to assess intervention recipients’
performance of the intervention skills in
• Questionnaires are sent to clinical staff in all
participating hospitals 3-month post interven
• Questionnaires are sent to clinical staff in all
participating hospitals allocated to receive
Lorencatto et al. Implementation Science  (2016) 11:163 Page 8 of 14
acquire pre-specified competence indicators prior to
intervention delivery [11].
The intervention providers for intervention 1 are
the NCA-assembled audit-writing groups. There will
be two writing groups: an enhanced writing group,
tasked with drafting feedback reports using the en-
hancement guidance manual; and a standard writing
group, tasked with drafting feedback reports as per
usual NCA practice. The enhanced writing group
will be trained via a full-day workshop, where inter-
vention developers will deliver a presentation
explaining each proposed enhancement, and facilitate
wider discussion of prototype enhanced feedback re-
ports and how these may be adapted to write feed-
back reports for the current audit topic. Initial skill
acquisition will be assessed by conducting a content
analysis of the first draft enhanced feedback re-
port(s). Two independent raters will assess whether
the five proposed enhancements and theoretically
consistent BCTs are ‘present’, ‘absent but should be
present’, or ‘not applicable’ in the draft report, and
inter-rater agreement assessed using Cohen’s kappa.
The percentage of applicable intervention compo-
nents present will be calculated.
The intervention providers for intervention 2 are
responsible for developing the web-based toolkit
(i.e. health psychologists, web designers) and provid-
ing the telephone support co-intervention (i.e.
health psychologists). Intervention providers will be
trained to deliver telephone support by an interven-
tion developer over three training sessions using a
standardised telephone support manual and practice
role plays. This manual specifies the intended con-
tent and format of telephone support calls in terms
of component BCTs. Intervention providers’ skill
acquisition will be assessed prior to intervention
delivery via audio-recorded, simulated role plays of
telephone support sessions. An independent rater
will content analyse role play transcripts and score
the proportion of manual-specified BCTs delivered
as intended.
Fidelity of delivery
Assessing fidelity of delivery during the intervention
period concerns whether interventions were delivered as
intended (i.e. adherence), ongoing treatment competency
(i.e. whether providers maintain skills acquired during
training) and monitoring for potential loss of treatment
differentiation between trial arms, due to delivery of
additional, unspecified intervention components and/or
potential contamination [11–13].
For intervention 1, in the intervention arm, ongoing
treatment competency will be encouraged by interven-
tion developers providing on-going support to the audit-
writing group during the drafting of feedback reports.
Intervention developers will iteratively review drafts of
reports and provide feedback on how to further incorp-
orate delivery of proposed enhancements and theoretic-
ally consistent BCTs. Subsequent fidelity of delivery (i.e.
adherence) will be assessed by conducting a content ana-
lysis of the final template enhanced feedback report(s).
The template report(s) will be coded by two independent
raters using a BCT taxonomy [10] to verify whether the
five manual-specified enhancements and theoretically
consistent BCTs are either ‘present’, ‘absent but should
be present’ or ‘not applicable’. Inter-rater reliability will
be assessed using Cohen’s kappa. Any additional, non-
manual specified BCTs present in the final template
feedback report(s) will be documented. The template
feedback reports for the standard/comparator arm will
be equivalently content analysed to monitor for any con-
tamination and loss of treatment differentiation. To
monitor delivery of feedback reports by NHSBT’s NCA,
the webpage for every hospital in each trial arm will be
examined to verify that the correct feedback reports
were uploaded according to cluster allocation (i.e. en-
hanced vs standard).
For intervention 2, fidelity of delivery for the final ver-
sion of the toolkit will be examined by conducting a
content analysis of the toolkit to assess whether intended
and theoretically consistent BCTs are present, absent
but should be present or not applicable. The NCA web-
page for all participating hospitals will be examined to
Table 1 BCC fidelity dimensions (Bellg et al. [11]) and their application in the AFFINITIE trial (Continued)
settings in which intervention might be
applied.
tion delivery to assess the extent to which
they read the feedback reports, discuss the
feedback reports with colleagues and imple
ment any change in light of the findings/
recommendations provided and possible
contextual influences on enactment.
• Semi-structured interviews with clinical staff in
a sub-sample of hospitals to examine in greater
depth the extent to which they read the
feedback reports, discussed the feedback reports
with colleagues and implemented any change
in light of the findings/recommendations
provided.
intervention 2 3-month post intervention
delivery to assess the extent to which they
disseminated the feedback, implement any
developed action plans, re-monitor their
clinical practice using the tools provided and
possible contextual influences on enactment
• Semi-structured interviews with clinical staff in
a sub-sample of hospitals to examine in
greater depth the extent to which they
disseminated the feedback, implemented any
developed action plans and re-monitored
their clinical practice using the tools provided
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verify that a link to the toolkit is present for hospitals
allocated to receive intervention 2 and absent for control
hospitals. For telephone support, fidelity of delivery will
be promoted through use of a manual and flow chart to
prompt delivery of intended BCTs. A log of all delivered
telephone support calls will be maintained and reviewed
to monitor whether all participating hospitals allocated
to receive intervention 2 received at least one initial tele-
phone support call. All telephone support sessions will
be audio-recorded. Adherence and ongoing treatment
competency will be assessed by transcribing a randomly
selected sub-sample of sessions (n = 18 in total; i.e. 9 per
trial arm receiving intervention 2; 6 per intervention
provider). Transcripts will be coded into component
BCTs to monitor whether intervention providers
continue to competently deliver BCTs according to man-
ual specification. Both content analyses of the toolkit
and telephone support transcripts will be conducted by
two independent raters and inter-rater reliability
assessed using Cohen’s kappa.
Fidelity of delivery will be quantified for both interven-
tions by assessing the proportion of manual-specified
content (i.e. % proposed enhancements/BCTs) delivered
as intended in the feedback reports/toolkit/telephone
support sessions, and also the proportion of hospitals
that received feedback reports, links to the toolkit and/
or telephone support, according to trial allocation. Con-
sensus in the literature suggests that 80 to 100% adher-
ence to intervention specifications represents ‘high’
fidelity of delivery, 51 to 79% represents ‘moderate’ fidel-
ity, and <50% or less represents ‘low’ fidelity [12, 21].
Fidelity of receipt, enactment and contextual influences
Receipt and enactment will be concurrently investigated
alongside contextual influences. Recommended strat-
egies for assessing receipt and enactment include object-
ive verification of intervention implementation where
possible or recipient self-report [11–13]. Receipt, enact-
ment and context will thus be assessed using a mixed
methods approach, combining objective web-analytics
data, questionnaires and semi-structured interviews.
Web-analytics data to assess engagement and enactment
For intervention 1, the NCA webpage has been pro-
grammed to record the number of times each feedback
report was downloaded by each hospital throughout the
intervention period. For intervention 2, the toolkit has
been programmed to record usage patterns during the
intervention period, including the number and duration
of logins, page views, and indicators of completion of
tools (i.e. adding/deleting characters). Patterns of
engagement throughout the intervention period will be
examined for both interventions and represented visually
using graphs.
Questionnaires and semi-structured interviews
Questionnaires will assess receipt, enactment and
contextual influences across all participating hospitals.
Approximately 3 months following intervention delivery,
an invitation to complete a web-based questionnaire will
be emailed to the NCA-listed clinical contact for the
audit at each participating site (i.e. nominated member
of the hospital transfusion team, typically transfusion
practitioner, leading audit data collection and response).
To also collect responses from the range of clinical staff
potentially involved in applying findings from the audit,
the initial contact will be asked to forward the question-
naire link and invitation email to at least two other clin-
ical staffs involved in transfusion—ideally a further
member of the hospital transfusion team and one repre-
sentative from the clinical specialty being audited (e.g.
anaesthetists/ surgeons for trial 1, which audits surgical
patient blood management). Respondent demographic
characteristics, including role/clinical specialty, will also
be recorded. The response rate will be calculated as the
percentage of participating sites (n = 155 Trial 1; n = 167
trial 2) for which at least one questionnaire response is
received.
Semi-structured interviews will be conducted in a sub-
sample of hospitals to enable more in-depth exploration
of receipt, enactment and contextual influences. Inter-
views lasting up to 1 h will be conducted via telephone
approximately 3 months following intervention delivery,
with up to three clinical staff members in three ran-
domly selected hospitals per trial arm (i.e. 3 hospitals ×
4 trial arms = 12 hospitals; 12 hospitals × 3 clinical staff
= 36 participants; 24 hospitals and 72 participants across
both trials). Clinical staff eligible to participate will
include two members of the hospital transfusion team
and a clinical staff member from the relevant specialty/
topic being audited.
Questionnaire items and interview topic guides will be
based on the Theoretical Domains Framework (TDF)
[22, 23] to enable systematic identification of barriers/
enablers to intervention recipients understanding, en-
gaging with and/or enacting feedback interventions as
intended. The TDF synthesises 128 constructs from 33
distinct behaviour change theories into 12 theoretical
domains. The TDF has been applied to investigate bar-
riers/enablers to behaviour change across a range of
clinical contexts, including transfusion [24–26]. It has
also been applied as part of intervention development in
AFFINITIE (Workstream 1; Fig. 1) to identify barriers/
enablers to how hospitals currently respond to transfu-
sion A&F delivered by NHSBT’s NCA [9]. The target be-
haviours of interest are the extent to which clinical staff
involved in transfusion decision making for elective sur-
gical (trial 1) or haematology patients (trial 2), initially
understand and engage with the feedback materials
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delivered by the NCA and subsequently act on recom-
mendations provided in the reports. Questionnaire and
interview topic guides will include at least one question
related to each of the 12 theoretical domains. Additional
file 1 provides sample questions for each domain.
Items related to fidelity of receipt will explore the ex-
tent to which participants initially engaged with and
understood the intervention. TDF domains of relevance
to receipt might thus include ‘knowledge’ (e.g.what the
key findings and recommendations from the feedback
reports were; whether participants understood how to
use the tools in the toolkit), and ‘memory, attention, de-
cision making’ (e.g. how readily participants were able to
extract key information for their hospital from the feed-
back materials). Items related to enactment will explore
how participants have subsequently acted upon the feed-
back. TDF domains of relevance to enactment might
thus include ‘motivation and goals’ and ‘behavioural
regulation’ (e.g. whether they have set goals or action
plans in light of feedback; If not, why not? Have they en-
countered any difficulties when trying to change practice
in light of feedback? If so, how have they overcome
these?), or ‘nature of the behaviour’ (e.g. how has your
response to this audit differed from what you normally
do when receiving blood transfusion feedback from the
NCA?). The TDF will also allow for potential contextual
factors influencing intervention enactment to be investi-
gated, for instance, via the domains ‘social Influences’
(e.g. How receptive have your clinical colleagues been to
making changes in response to the audit findings?) and
‘environmental context and resources’ (e.g. To what ex-
tent does your team/site have the necessary resources to
change practice in light of feedback? If not, what add-
itional resources would be required?) The questionnaires
and topic guides will be piloted and reviewed by two
haematologists to ensure clinical face validity.
Questionnaire responses and web-analytics data will
be summarised descriptively. Transcripts of audio-
recorded interviews will be analysed using content ana-
lysis following a framework analysis approach [27, 28].
Using the TDF as a coding framework, participant re-
sponses within each transcript will be coded into TDF
domains they are judged to represent. For example, ‘I do
not feel confident that I will be able to act on any of the
recommendations provided in the feedback reports’,
would be coded as TDF domain ‘beliefs about capabil-
ities’. A 20% sub-sample of transcripts will be double-
coded to assess inter-rater reliability using Cohen’s
kappa. Responses coded into each domain will subse-
quently compared across transcripts, sorting responses
expressing similar views into groups. A belief statement
will be inductively generated for each cluster of grouped
responses, summarising the shared view across partici-
pants as to the role that domain plays in hindering or
enabling intervention enactment. Generated belief state-
ments will then be reviewed to identify those belief
statements representing the likely most important bar-
riers/enablers based on three criteria: (1) belief state-
ment frequency across participants; (2) presence of
conflicting beliefs across participants; and (3) expressed
importance by participants [27].
Association with outcomes
Systematic reviews demonstrate that few fidelity assess-
ments examine associations between fidelity and out-
comes [29]. After quantitative process evaluation data
(i.e. extent of fidelity of delivery, receipt/enactment
questionnaire responses; web-analytics data) and out-
come data (i.e. proportion of unnecessary transfusions)
have been analysed, we will explore whether fidelity me-
diates the impact of the randomised interventions on
trial outcomes using causal mediation analyses [30].Full
details will be included in the statistical analysis plan for
the trials.
Triangulation
In line with recommendations for mixed methods re-
search, qualitative (e.g. semi-structured interviews) and
quantitative (e.g. questionnaires, web-analytics) findings
will be integrated following a triangulation protocol (i.e.
methodological triangulation) [31–33]. To examine con-
sistencies in key fidelity findings across the two audit
topics being evaluated, findings will also be triangulated
across trials 1 and 2 (i.e. data source triangulation)
[32].For each key finding, data from each data set will be
tabulated in a ‘convergence coding matrix’. The extent of
similarity of findings across data sets will be compared
and categorised as representing either full agreement
(data convergence), partial agreement (complementarity
between data), conflicting findings (discord) or silence
(finding identified in only one data source and no add-
itional sources) [31, 32, 34]. Triangulated findings will
be presented schematically to illustrate the relationship
between fidelity dimensions and outcomes.
Trial status
At the time of submission of this protocol (November
2016), the two enhanced A&F interventions had been
delivered for both trials. Fidelity data on training, deliv-
ery, receipt and enactment had been collected for trial 1.
Only data on fidelity of training and delivery had been
collected for trial 2. Outcome data collection had com-
menced for trial 1 but not trial 2. No outcome or fidelity
data from either trial were cleaned or analysed prior to
submission.
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Discussion
This protocol describes planned strategies for assessing
intervention fidelity as part of the process evaluation of
two linked cluster RCTs in the AFFINITIE programme.
A strength of the present process evaluation is the
multidimensional approach to fidelity data collection.
The planned methods and five fidelity dimensions
assessed are also in line with the four process evaluation
functions proposed by the recently published Medical
Research Council guidance for designing and conducting
process evaluations of complex interventions [35]: (1)
ensuring interventions’ core components, theoretical
underpinning and key assumptions are clearly articu-
lated (i.e. Design); (2) examining extent of implementa-
tion during the intervention period (i.e. training/
delivery); (3) examining contextual factors affecting
intervention delivery and functioning; and (4) investigat-
ing mechanisms of impact through which observed out-
comes are achieved, including extent of engagement by
intervention recipients (i.e. receipt/enactment; mediation
analyses).
Results from the fidelity assessment will contribute to
an in depth investigation of how the interventions
‘worked’ (or not), which will contribute to interpretation
of observed trial outcomes. There are a number of pos-
sible scenarios:
1. If the trial outcome identifies significant reductions
in the proportion of unnecessary transfusions, and
the proposed fidelity assessments identify the
interventions were implemented with high fidelity,
with minimum contextual barriers, and that extent
of fidelity mediated observed outcomes, then it may
be more confidently inferred that observed
outcomes are attributable to the enhanced A&F
interventions.
2. Alternatively, if the interventions are not effective
and there is evidence that fidelity was poor or
inconsistent, it would be premature to dismiss the
interventions as ineffective; given they were not
implemented as intended and thus not evaluated. It
may also be the case that poor fidelity is associated
with delivery or enactment of unplanned BCTs that
may have negatively impacted outcomes.
3. Conversely, the trial may identify significant
reductions in unnecessary transfusions, despite poor
fidelity. If so, delivery of unplanned BCTs or
contextual factors may have interacted with
intervention delivery to influence practice (e.g.
transfusion clinical staff in intervention hospitals
being more motivated to change than those in the
control hospitals as a result of more contact with
intervention providers). Alternatively, the
interventions may have operated through
mechanisms and pathways other than those
investigated in the fidelity assessment.
4. Lastly, no significant changes in unnecessary
transfusions may be observed, despite good fidelity.
If so, it could be inferred that the interventions are
not effective and should not be scaled up into
routine feedback practice. Alternatively, the process
evaluation may identify unexpected factors that
contributed to the observed changes in clinical
practice across all participating hospitals, including
contamination between trial arms, loss of treatment
differentiation and contextual factors (i.e. new
national transfusion guidelines).
Any such scenarios would provide valuable findings
that would contribute to the scientific knowledge, evi-
dence and theory regarding what makes for more effect-
ive A&F. Furthermore, an ongoing debate in the fidelity
literature is that of ‘strict fidelity’ vs ‘adaptation’ (to key
contextual factors), and the unresolved question of ‘how
much’ fidelity is necessary or beneficial [12, 36]. For
pragmatic trials such as the AFFINITIE cluster-RCTs,
where variation and localised tailoring are likely inevit-
able, uniform or strict 100% fidelity may not be feasible
to achieve nor necessarily desirable. General consensus
in the literature is that 80 to 100% fidelity is considered
‘high’ and ‘good’ [12], yet there is insufficient evidence to
support this. The proposed moderator/mediator analyses
may identify that improved outcomes are achieved, for
instance, with a ‘moderate’ degree of fidelity (e.g. 60%);
thus implying a permissible degree of loss of interven-
tion fidelity or adaptation. Such findings would be of
interest to researchers developing future A&F interven-
tions, as well as to policy makers and service commis-
sioners, by providing feasibility data that may inform
how and to what extent the interventions may be gener-
alised in new settings or implemented on a larger scale,
while maintaining similar benefits. This is the focus of
Workstream 4 of the AFFINITIE programme (Fig. 1),
which aims to explore lessons learned regarding A&F in
the context of blood transfusion that may be generalised
to A&F in other clinical contexts.
There are a number of limitations and challenges to the
proposed process evaluation. The trials in AFFINITIE are
pragmatic evaluations, embedded in the existing NHSBT
NCA A&F programme. The trials and process evaluation
are thus restricted by what is feasible to deliver and evalu-
ate in this context. One notable challenge, highlighted in
the intervention development process, is in describing
‘standard practice.’ A content analysis of existing NCA
feedback reports and interviews with clinical transfusion
staff highlighted significant variability in the content and
structure of existing feedback reports and how hospitals
currently respond to transfusion A&F. The lack of clarity
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as to what constitutes standard practice makes it difficult
to establish at what point practice in the intervention arms
differs from ‘usual practice,’ and whether or not practice
has changed as a result of the interventions delivered.
An additional limitation, and potential source of con-
tamination, is that members of the intervention develop-
ment team are involved in conducting the process
evaluation. This increases risk of biasing analysis of
process evaluation data. The MRC process evaluation
guidance [35] highlights the importance of being reflective
of the relationship and boundaries between intervention
developers, implementers and evaluators and recom-
mends seeking occasional critical review from independ-
ent peers. The AFFINITIE Programme Steering Group
provides oversight to the conduct of all elements of the
programme and includes an independent chair and expert
members who are familiar with the models and methods
being used in AFFINITIE.
It has been argued that if process evaluations are to be
funded and conducted, it is important that the protocol
and findings from the process evaluation are transpar-
ently reported and published, as is standard practice for
outcome evaluations [35, 37]. This is particularly import-
ant for fidelity investigations. While the BCC fidelity
framework provides a synthesised conceptualisation and
definition of different fidelity dimensions, the authors
themselves acknowledge that there is little standardised
guidance on how to operationalise each dimension, and
a consequent need for further empirical examples of
how each dimension has been quantified and interpreted
[14, 38]. It is thus hoped that publishing the fidelity
protocol and findings for the AFFINITIE process evalu-
ation will provide a methodological contribution to the
fidelity literature that may inform future fidelity assess-
ments in other contexts.
Conclusions
We have presented the protocol for a multidimensional
assessment of intervention fidelity as part of the process
evaluation of two enhanced A&F interventions to reduce
unnecessary blood transfusions. It is anticipated that find-
ings from the process evaluation will provide information
critical to the interpretation of the trial outcomes. This
protocol also contributes to the advancement of the
process evaluation methods by illustrating the application
of a comprehensive, multidimensional framework for
assessing intervention fidelity, which may inform the de-
sign of future fidelity assessments.
Additional file
Additional file 1: Sample semi-structured interview questions and
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